K.J. Harrison & Partners’s Zymeworks ZYME Stock Holding History

K.J. Harrison & Partners’s Portfolio ZYME Stock Details ZYME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-30,000	Closed	-$876K	–	410
2021 Q3	$876K	Buy	+30,000	New	+$997K	0.13%	166
2021 Q1	–	Sell	-90,000	Closed	-$4.25M	–	381
2020 Q4	$4.25M	Buy	90,000 +50,000	+125%	+$2.32M	0.69%	37
2020 Q3	$1.86M	Buy	40,000 +30,000	+300%	+$1.03M	0.39%	88
2020 Q2	$361K	Hold	10,000	–	–	0.1%	150
2020 Q1	$355K	Hold	10,000	–	–	0.2%	89
2019 Q4	$455K	Hold	10,000	–	–	0.11%	135
2019 Q3	$246K	Sell	10,000 -20,000	-67%	-$501K	0.07%	149
2019 Q2	$659K	Buy	30,000 +15,000	+100%	+$275K	0.21%	98
2019 Q1	$249K	Hold	15,000	–	–	0.09%	137
2018 Q4	$219K	Buy	15,000 +3,000	+25%	+$39.4K	0.13%	107
2018 Q3	$189K	Buy	+12,000	New	+$172K	0.05%	181

Other funds holding ZYME

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

K.J. Harrison & Partners's ZYME Position: Q4 2021 in Review

K.J. Harrison & Partners sold out of Zymeworks (ZYME) in Q4 2021, closing a stake of 30,000 shares — an estimated $876K sold.

K.J. Harrison & Partners first reported a position in ZYME in Q3 2018 and held it in 11 quarters. The position peaked at $4.25M in Q4 2020. 114 funds tracked by Wall St. Rank hold ZYME as of Q4 2021.

K.J. Harrison & Partners reported no remaining Zymeworks position as of Q4 2021 after selling out during the quarter.
K.J. Harrison & Partners sold 30,000 Zymeworks shares in Q4 2021, an estimated $876K.
K.J. Harrison & Partners first reported a position in Zymeworks in Q3 2018 and held it in 11 quarters.
K.J. Harrison & Partners's Zymeworks position peaked at $4.25M in Q4 2020.
114 funds tracked by Wall St. Rank held Zymeworks as of Q4 2021.

Based on K.J. Harrison & Partners's 13F filing for Q4 2021, filed 26 Jan 2022.